UnitedHealth Group (UNH) Stock

$529.44 -0.60 (-0.11%)
Market Cap: $487.24B | NYSE

UnitedHealth Group Chart


Company Profile

Price: $529.44

Market Cap: $487.24B

Exchange: NYSE

CEO: Sir Andrew Philip Witty

Sector: Healthcare

Industry: Medical - Healthcare Plans

Employees: 440.00K

Headquarters: Minnetonka, MN

Business Summary

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

UnitedHealth Group News

Trade Tracker: Stephanie Link buys more UnitedHealth and Chipotle

Stephanie Link, CIO at Hightower, joins CNBC's 'Halftime Report' to detail her latest buys.

News image

UnitedHealth raises concerns over Bill Ackman's post on X with SEC

UnitedHealth has reached out to the U.S. Securities and Exchange Commission about billionaire investor Bill Ackman's now-deleted post on social media platform X that said he would take a short position in the healthcare conglomerate.

News image

Bill Ackman Sends UnitedHealth Stock Lower With Deleted Tweet: Here's What He Said

Hedge fund manager Bill Ackman sent shares of UnitedHealth Group UNH lower with a tweet alleging overstated profits, which comes as the health insurance company faces more scrutiny after the death of an executive.

News image

Final Trades: Energy Transfer, Vertex Pharma, UnitedHealth and Axon Enterprise

The Investment Committee give you their top stocks to watch for the second half.

News image

2 Top Dividend Stocks to Buy If You Have $1,000 to Invest

Buying top dividend stocks and holding them long-term can be a great approach to building your investment portfolio. It boils down to holding shares of companies that have historically provided reliable dividends (as well as dividend growth) in all sorts of market environments.

News image

Final Trades: Cisco, UnitedHealth and Walmart

The Investment Committee gives you their top stocks to watch for the second half.

News image

U.S. & Europe Ambulatory Surgery Centers Market 2025-2030, Featuring Analysis of Leading Players - Envision Healthcare, TH Medical, Pediatrix Medical Group, TeamHealth, UnitedHealth Group & More

Orthopedics accounted for the largest revenue share of 26.7% in 2024. The integration of AI-driven platforms and advanced analytics to enhance care coordination and surgical outcomes is a key driving factor for this segment. Orthopedics accounted for the largest revenue share of 26.7% in 2024. The integration of AI-driven platforms and advanced analytics to enhance care coordination and surgical outcomes is a key driving factor for this segment.

News image

Is UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

News image

Change Healthcare Breach Impacted 190 Million Americans

The biggest medical-related data breach in U.S. history was even larger than first estimated. The ransomware attack on UnitedHealth's Change Healthcare business last year impacted around 190 million people, almost double past estimates, TechCrunch reported Friday (Jan. 24).

News image

UnitedHealth confirms 190 million Americans affected by hack at tech unit, TechCrunch reports

The cyberattack at UnitedHealth's tech unit Change affected the personal information of 190 million Americans, TechCrunch reported on Friday.

News image

UnitedHealth confirms 190 million Americans affected by Change Healthcare data breach

UnitedHealth has confirmed the ransomware attack on its Change Healthcare unit last February affected around 190 million people in America — nearly double previous estimates.

News image

US drops appeal in case over UnitedHealth Medicare plans' rating

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the public star ratings it gave to UnitedHealth's privately administered Medicare health insurance plans, which the insurer said would cost it millions of dollars from lost customers.

News image

Final Trades: Docusign, Emcor Group, UnitedHealth and Guidewire Software

The Investment Committee give you their top stocks to watch for the second half.

News image

UnitedHealth Group Incorporated (UNH) Is a Trending Stock: Facts to Know Before Betting on It

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

News image

The Zacks Analyst Blog Tesla, UnitedHealth Group, Oracle and Earth Science Tech

Tesla, UnitedHealth Group, Oracle and Earth Science Tech are included in this Analyst Blog.

News image

UnitedHealthcare names a new CEO after Brian Thompson's fatal shooting

UnitedHealthcare named Tim Noel as its CEO, seven weeks after Brian Thompson's fatal shooting. Noel joined the company in 2007 and was most recently the head of its Medicare and retirement unit.

News image

UnitedHealthcare announces new CEO after killing of Brian Thompson

UnitedHealth Group named Tim Noel the new CEO of the company's insurance division, UnitedHealthcare, after the targeted killing of former CEO Brian Thompson.

News image

UnitedHealth taps insider Tim Noel to replace slain exec Brian Thompson as CEO of insurance unit

The brazen killing of Thompson on Dec. 4 ignited a broad conversation about the frustrations of navigating the US healthcare system.

News image

UnitedHealth taps Medicare head as CEO of insurance business

UnitedHealth Group said on Thursday it has appointed Tim Noel, the head of its Medicare business, to replace late CEO Brian Thompson as the head of its insurance unit.

News image

UnitedHealth names Tim Noel UnitedHealthcare CEO

CNBC's Bertha Coombs joins 'Closing Bell' to report on UnitedHealth annoucning its CEO successor.

News image

UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

UnitedHealthcare tapped Tim Noel, a company veteran, as its new CEO following the fatal, targeted shooting of its former top executive, Brian Thompson, in Manhattan in December.  Noel served as the head of Medicare and Retirement at UnitedHealthcare, the largest private health insurer in the U.S. and the insurance arm of UnitedHealth Group.

News image

UnitedHealth Group Names Successor For Slain UnitedHealthcare CEO Brian Thompson

UnitedHealth Group Thursday announced veteran internal executive Tim Noel will become chief executive of the company's health insurance business, UnitedHealthcare.

News image

Is UnitedHealth a Buy After Q4 Domestic Commercial Membership Growth?

UNH's Optum Health is expected to serve about 5.4 million value-based care patients in 2025.

News image

3 Unstoppable Dividend Stocks That Can Be Pillars to Build Your Portfolio Around

If you're a new investor, want some recurring dividend income, or just want some top stocks to build your portfolio around, it's important to focus on businesses with strong fundamentals and room to generate steady growth for years to come.

News image

Final Trades: Disney, Affiliated Managers, UnitedHealth and Block

The Investment Committee give you their top stocks to watch for the second half.

News image

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

2024 was an excellent year for the major stock market indexes. But the Dow Jones Industrial Average (^DJI 0.78%) had just a 12.9% return, compared to 23.3% for the S&P 500 (^GSPC 1.00%) and 28.6% for the Nasdaq Composite.

News image

UnitedHealth: Challenging Times Trigger A Contrarian Buy Opportunity

UNH has been sold off, thanks to the market's overreaction to the FQ4'24 top-line miss and mixed FY2025 guidance, as medical costs continue to grow. Despite headwinds, robust growth in Optum Rx and OptumHealth segments may balance UnitedHealthcare challenges, supporting the management's ambitious FY2025 targets. The consensus downgrades and UNH's discounted valuations highlight the market's pessimism, with it presenting a contrarian Buy opportunity.

News image

The Score: Goldman Sachs, Nvidia, UnitedHealth and More Stocks That Defined the Week

Here are some of the major companies whose stocks moved on the week's news.

News image

ETFs in Focus Post UnitedHealth's Mixed Q4 Results

UnitedHealth breezes past the Zacks Consensus Estimate for earnings but misses the same for revenues.

News image

Buy, Sell, Or Hold UNH Stock At $510?

UnitedHealth Group (NYSE: UNH) recently reported its Q4 results, with revenues missing and earnings exceeding the street expectations. The company reported revenue of $100.8 billion and adjusted earnings of $6.81 per share, compared to the consensus estimates of $101.8 billion and $6.72, respectively.

News image

UnitedHealth Group Earnings

This section highlights UnitedHealth Group's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.

Next Earnings Date

Date: April 15, 2025
Time: Before Market
Est. EPS: $7.24
Status: Unconfirmed

Last Earnings Results

Date: January 16, 2025
EPS: $6.81
Est. EPS: $6.74
Revenue: $100.81B

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-01-16 $6.74 $6.81
Read Transcript Q3 2024 2024-10-15 $7.00 $7.15
Read Transcript Q2 2024 2024-07-16 $6.65 $6.80
Read Transcript Q1 2024 2024-04-16 $6.61 $6.91
Read Transcript Q4 2023 2024-01-12 $5.98 $6.16
Read Transcript Q3 2023 2023-10-13 $6.32 $6.56
Read Transcript Q2 2023 2023-07-14 $5.99 $6.14
Read Transcript Q1 2023 2023-04-14 $6.13 $6.26

Financial Statements

Access annual & quarterly financial statements for UnitedHealth Group, including income statements, balance sheets, and cash flow statements..

Annual Income Statement

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Revenue $400.28B $367.53B $322.13B $285.27B $255.64B
Cost of Revenue $310.88B $280.66B $244.54B $217.94B $190.14B
Gross Profit $89.40B $86.87B $77.59B $67.33B $65.50B
Gross Profit Ratio 22.33% 23.64% 24.09% 23.60% 25.62%
Research and Development Expenses $- $- $- $- $-
General and Administrative Expenses $- $- $- $- $-
Selling and Marketing Expenses $- $- $- $- $-
Selling General and Administrative Expenses $57.11B $54.63B $- $- $-
Other Expenses $- $-117.00M $3.40B $3.10B $2.89B
Operating Expenses $57.11B $54.51B $51.18B $45.68B $44.59B
Cost and Expenses $367.99B $339.26B $295.73B $263.63B $234.74B
Interest Income $- $- $- $- $-
Interest Expense $-3.91B $3.25B $2.09B $1.66B $1.66B
Depreciation and Amortization $4.10B $3.97B $3.40B $3.10B $2.89B
EBITDA $9.77B $32.52B $31.84B $27.07B $25.30B
EBITDA Ratio 2.44% 8.85% 9.25% 8.68% 9.31%
Operating Income $32.29B $32.36B $28.43B $23.97B $22.41B
Operating Income Ratio 8.07% 8.80% 8.83% 8.40% 8.76%
Total Other Income Expenses Net $-12.22B $-3.25B $-2.09B $-1.66B $-1.66B
Income Before Tax $20.07B $29.11B $26.34B $22.31B $20.74B
Income Before Tax Ratio 5.01% 7.92% 8.18% 7.82% 8.11%
Income Tax Expense $-4.83B $5.97B $5.70B $4.58B $4.97B
Net Income $14.40B $22.38B $20.12B $17.29B $15.40B
Net Income Ratio 3.60% 6.09% 6.25% 6.06% 6.03%
EPS $15.51 $24.12 $21.54 $18.33 $16.28
EPS Diluted $15.51 $23.86 $21.18 $18.08 $16.03
Weighted Average Shares Outstanding 929.00M 928.00M 934.00M 943.00M 946.00M
Weighted Average Shares Outstanding Diluted 929.00M 938.00M 950.00M 956.00M 961.00M
SEC Filing Source Source Source Source Source


Income Statement Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Revenue $100.81B $100.82B $97.86B $98.78B $93.25B $91.36B $91.79B $91.13B $82.79B $80.89B $80.33B $80.15B $73.74B $72.34B $71.32B $70.20B $65.47B $65.11B $62.14B $64.42B
Cost of Revenue $79.50B $77.79B $76.80B $76.79B $72.42B $68.97B $70.02B $69.25B $61.91B $60.94B $60.69B $61.01B $56.16B $55.10B $54.21B $52.48B $49.70B $49.57B $42.18B $48.69B
Gross Profit $21.31B $23.03B $21.06B $21.99B $20.82B $22.39B $21.77B $21.88B $20.88B $19.95B $19.64B $19.14B $17.58B $17.23B $17.11B $17.72B $15.76B $15.54B $19.96B $15.73B
Gross Profit Ratio 21.14% 22.84% 21.52% 22.26% 22.33% 24.51% 23.72% 24.01% 25.22% 24.67% 24.45% 23.88% 23.84% 23.82% 24.00% 25.24% 24.08% 23.87% 32.12% 24.42%
Research and Development Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
General and Administrative Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling and Marketing Expenses $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Selling General and Administrative Expenses $13.54B $13.28B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Expenses $- $- $1.02B $997.00M $974.00M $14.86B $1.02B $970.00M $982.00M $828.00M $802.00M $788.00M $771.00M $796.00M $778.00M $758.00M $732.00M $719.00M $717.00M $723.00M
Operating Expenses $13.54B $12.68B $14.18B $15.07B $14.31B $14.86B $14.83B $14.60B $13.99B $12.49B $12.51B $12.19B $12.04B $11.52B $11.14B $10.98B $12.25B $10.89B $10.72B $10.74B
Cost and Expenses $93.03B $92.11B $90.98B $91.86B $86.74B $83.83B $84.85B $83.84B $75.90B $73.43B $73.20B $73.20B $68.20B $66.62B $65.34B $63.46B $61.95B $60.46B $52.90B $59.42B
Interest Income $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Interest Expense $-1.00B $1.07B $985.00M $844.00M $830.00M $834.00M $828.00M $754.00M $676.00M $516.00M $467.00M $433.00M $431.00M $422.00M $410.00M $397.00M $401.00M $395.00M $430.00M $437.00M
Depreciation and Amortization $1.04B $1.04B $1.02B $997.00M $974.00M $1.01B $1.02B $970.00M $982.00M $828.00M $802.00M $788.00M $771.00M $796.00M $778.00M $758.00M $732.00M $719.00M $717.00M $723.00M
EBITDA $4.57B $9.73B $7.67B $1.84B $7.48B $8.54B $9.08B $9.06B $7.87B $8.29B $7.93B $7.74B $6.31B $6.51B $6.76B $7.50B $4.25B $5.37B $9.96B $5.72B
EBITDA Ratio 4.54% 9.65% 8.07% 8.01% 8.03% 9.34% 8.68% 9.06% 9.51% 10.25% 9.88% 9.65% 8.56% 9.00% 9.47% 10.68% 6.49% 8.25% 16.03% 8.88%
Operating Income $7.77B $8.71B $7.88B $7.93B $7.69B $8.53B $8.06B $8.09B $6.89B $7.46B $7.13B $6.95B $5.54B $5.71B $5.98B $6.74B $3.52B $4.65B $9.24B $5.00B
Operating Income Ratio 7.71% 8.64% 8.05% 8.03% 8.25% 9.33% 8.78% 8.87% 8.32% 9.22% 8.88% 8.67% 7.51% 7.90% 8.38% 9.60% 5.37% 7.14% 14.87% 7.76%
Total Other Income Expenses Net $-982.00M $-1.09B $-2.21B $-7.93B $-830.00M $-834.00M $-828.00M $-754.00M $-676.00M $-516.00M $-467.00M $-433.00M $-431.00M $-422.00M $-410.00M $-397.00M $-401.00M $-395.00M $-430.00M $-437.00M
Income Before Tax $6.79B $7.61B $5.67B $1.00M $6.86B $7.69B $7.23B $7.33B $6.21B $6.95B $6.67B $6.52B $5.11B $5.29B $5.57B $6.34B $3.12B $4.26B $8.81B $4.56B
Income Before Tax Ratio 6.74% 7.55% 5.79% 0.00% 7.36% 8.42% 7.88% 8.05% 7.51% 8.59% 8.30% 8.13% 6.93% 7.31% 7.81% 9.03% 4.76% 6.54% 14.18% 7.08%
Income Tax Expense $-1.01B $1.36B $1.24B $1.22B $1.18B $1.65B $1.57B $1.56B $1.31B $1.56B $1.47B $1.37B $919.00M $1.10B $1.20B $1.36B $764.00M $1.00B $2.12B $1.09B
Net Income $5.54B $6.05B $4.22B $-1.41B $5.46B $5.84B $5.47B $5.61B $4.76B $5.26B $5.07B $5.03B $4.07B $4.09B $4.27B $4.86B $2.21B $3.17B $6.64B $3.38B
Net Income Ratio 5.50% 6.01% 4.31% -1.43% 5.85% 6.39% 5.96% 6.16% 5.75% 6.50% 6.31% 6.27% 5.52% 5.65% 5.98% 6.93% 3.38% 4.87% 10.68% 5.25%
EPS $5.98 $6.56 $4.58 $-1.53 $5.90 $6.31 $5.89 $6.01 $5.10 $5.63 $5.42 $5.35 $4.33 $4.34 $4.52 $5.15 $2.34 $3.34 $6.99 $3.57
EPS Diluted $5.98 $6.51 $4.54 $-1.53 $5.83 $6.24 $5.82 $5.95 $5.03 $5.55 $5.34 $5.27 $4.26 $4.28 $4.46 $5.08 $2.30 $3.30 $6.91 $3.52
Weighted Average Shares Outstanding 927.00M 923.00M 921.00M 920.00M 924.00M 926.00M 930.00M 933.00M 934.00M 935.00M 935.00M 939.00M 941.00M 942.00M 943.00M 944.00M 946.00M 949.00M 950.00M 947.00M
Weighted Average Shares Outstanding Diluted 927.00M 930.00M 928.00M 922.00M 935.00M 936.00M 940.00M 943.00M 947.00M 948.00M 950.00M 954.00M 955.00M 955.00M 956.00M 957.00M 961.00M 962.00M 960.00M 962.00M
SEC Filing Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source Source

Annual Balance Sheet

Breakdown December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020 December 31, 2019
Cash and Cash Equivalents $25.43B $23.36B $21.38B $16.92B $10.98B
Short Term Investments $4.20B $4.55B $2.53B $2.86B $3.26B
Cash and Short Term Investments $29.63B $27.91B $23.91B $19.78B $14.24B
Net Receivables $38.97B $30.45B $28.08B $25.40B $21.46B
Inventory $- $- $- $- $-
Other Current Assets $9.84B $10.71B $9.77B $8.53B $6.93B
Total Current Assets $78.44B $69.07B $61.76B $53.72B $42.63B
Property Plant Equipment Net $11.45B $10.13B $8.97B $8.63B $8.70B
Goodwill $103.73B $93.35B $75.80B $71.34B $65.66B
Intangible Assets $15.19B $14.40B $10.04B $10.86B $10.35B
Goodwill and Intangible Assets $118.93B $107.75B $85.84B $82.19B $76.01B
Long Term Investments $- $43.73B $43.11B $41.24B $37.21B
Tax Assets $- $2.77B $-94.81B $-90.82B $-84.71B
Other Non-Current Assets $64.91B $12.26B $107.33B $102.33B $94.05B
Total Non-Current Assets $195.28B $176.64B $150.45B $143.57B $131.25B
Other Assets $- $- $- $- $-
Total Assets $273.72B $245.71B $212.21B $197.29B $173.89B
Account Payables $31.96B $56.77B $49.13B $44.37B $40.70B
Short Term Debt $4.27B $3.11B $3.62B $4.82B $3.87B
Tax Payables $- $- $- $- $-
Deferred Revenue $3.35B $3.08B $2.57B $2.84B $2.62B
Other Current Liabilities $59.47B $26.28B $22.98B $20.39B $14.60B
Total Current Liabilities $99.05B $89.24B $78.29B $72.42B $61.78B
Long Term Debt $62.12B $54.51B $42.38B $38.65B $36.81B
Deferred Revenue Non-Current $3.35B $2.77B $-3.27B $-3.37B $-2.99B
Deferred Tax Liabilities Non-Current $3.02B $2.77B $3.27B $3.37B $2.99B
Other Non-Current Liabilities $11.94B $15.61B $15.05B $15.68B $13.14B
Total Non-Current Liabilities $80.44B $70.12B $57.44B $54.33B $49.95B
Other Liabilities $-4.70B $- $- $- $-
Total Liabilities $174.80B $159.36B $135.73B $126.75B $111.73B
Preferred Stock $- $- $- $- $2.81B
Common Stock $9.00M $9.00M $10.00M $10.00M $9.00M
Retained Earnings $95.77B $86.16B $77.13B $69.30B $61.18B
Accumulated Other Comprehensive Income Loss $-7.03B $-8.39B $-5.38B $-3.81B $-3.58B
Other Total Stockholders Equity $- $- $- $- $7.00M
Total Stockholders Equity $88.76B $77.77B $71.76B $65.49B $60.44B
Total Equity $98.92B $86.35B $76.48B $70.54B $62.16B
Total Liabilities and Stockholders Equity $273.72B $245.71B $212.21B $197.29B $173.89B
Minority Interest $10.16B $8.57B $4.72B $5.05B $1.73B
Total Liabilities and Total Equity $273.72B $245.71B $212.21B $197.29B $173.89B
Total Investments $4.20B $71.64B $45.65B $44.10B $40.47B
Total Debt $62.54B $57.62B $46.00B $43.47B $40.68B
Net Debt $37.11B $34.26B $24.63B $26.55B $29.69B


Balance Sheet Charts

Breakdown December 31, 2024 September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020
Cash and Cash Equivalents $29.11B $32.40B $26.29B $28.41B $25.43B $38.91B $46.28B $46.50B $23.36B $38.84B $24.61B $25.48B $21.38B $21.09B $19.83B $19.95B $16.92B $17.55B $22.33B $21.57B
Short Term Investments $- $4.73B $5.04B $4.30B $4.20B $5.18B $46.28B $46.50B $4.55B $3.68B $3.35B $2.91B $2.53B $2.79B $2.73B $2.96B $2.86B $3.26B $3.27B $2.88B
Cash and Short Term Investments $29.11B $37.13B $31.32B $32.71B $29.63B $44.10B $46.28B $46.50B $27.91B $42.53B $27.96B $28.40B $23.91B $23.87B $22.56B $22.92B $19.78B $20.81B $25.59B $24.45B
Net Receivables $22.36B $47.48B $49.88B $46.48B $38.97B $38.42B $34.08B $37.11B $17.68B $30.73B $31.16B $30.86B $14.22B $28.23B $27.22B $27.53B $12.87B $25.40B $23.98B $24.89B
Inventory $- $- $- $-74.89B $-68.60B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Other Current Assets $34.30B $7.64B $10.84B $9.75B $9.84B $9.38B $9.51B $10.29B $23.48B $9.68B $9.23B $9.77B $23.64B $9.51B $9.14B $9.06B $21.07B $8.61B $9.35B $9.47B
Total Current Assets $85.78B $92.26B $92.04B $88.94B $78.44B $91.91B $89.87B $93.89B $69.07B $82.94B $68.36B $69.03B $61.76B $61.61B $58.92B $59.51B $53.72B $54.82B $58.92B $58.81B
Property Plant Equipment Net $- $10.14B $9.80B $10.43B $11.45B $11.07B $10.93B $10.64B $10.13B $9.47B $9.42B $9.18B $8.97B $8.73B $8.73B $8.50B $8.63B $8.15B $8.13B $8.17B
Goodwill $- $105.98B $105.44B $105.66B $103.73B $101.70B $101.67B $100.41B $93.35B $83.90B $84.16B $77.55B $75.80B $75.44B $75.83B $72.16B $71.34B $68.09B $67.87B $65.30B
Intangible Assets $- $23.59B $14.73B $15.54B $15.19B $15.20B $15.64B $16.16B $14.40B $10.79B $11.29B $9.92B $10.04B $10.44B $10.81B $10.84B $10.86B $10.37B $10.55B $10.20B
Goodwill and Intangible Assets $- $129.57B $120.17B $121.21B $118.93B $116.90B $117.31B $116.57B $107.75B $94.69B $95.44B $87.47B $85.84B $85.87B $86.63B $83.00B $82.19B $78.46B $78.42B $75.50B
Long Term Investments $52.35B $48.69B $46.11B $5.50B $47.61B $45.47B $45.99B $46.88B $43.73B $41.56B $42.43B $42.35B $43.11B $44.78B $44.06B $42.41B $41.24B $39.18B $36.78B $36.58B
Tax Assets $- $4.01B $3.63B $4.17B $4.70B $2.21B $2.50B $2.83B $4.60B $1.66B $2.58B $2.95B $-94.81B $3.65B $3.64B $3.60B $-90.82B $3.34B $3.29B $3.03B
Other Non-Current Assets $160.15B $18.65B $14.31B $53.96B $17.30B $14.50B $13.57B $12.86B $10.43B $12.75B $11.94B $10.25B $107.33B $8.41B $8.31B $8.15B $102.33B $7.01B $6.95B $6.98B
Total Non-Current Assets $212.50B $207.05B $194.02B $195.27B $199.98B $190.16B $190.29B $189.78B $176.64B $160.13B $161.82B $152.21B $150.45B $151.44B $151.38B $145.66B $143.57B $136.15B $133.56B $130.26B
Other Assets $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Assets $298.28B $299.31B $286.06B $284.21B $278.42B $282.06B $280.16B $283.68B $245.71B $243.06B $230.17B $221.24B $212.21B $213.04B $210.29B $205.17B $197.29B $190.97B $192.48B $189.07B
Account Payables $- $- $63.43B $64.77B $31.96B $63.96B $61.46B $61.66B $56.77B $56.30B $54.12B $53.73B $49.13B $24.29B $23.01B $47.83B $44.37B $42.34B $44.62B $45.62B
Short Term Debt $4.54B $3.91B $11.37B $9.79B $5.31B $5.29B $6.32B $9.93B $3.11B $3.23B $5.59B $6.70B $3.62B $3.62B $3.87B $8.84B $4.82B $3.90B $6.16B $15.83B
Tax Payables $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Deferred Revenue $- $3.32B $2.57B $3.21B $3.35B $15.31B $14.85B $14.49B $3.08B $12.85B $2.21B $2.67B $2.57B $2.56B $2.37B $2.61B $2.84B $2.39B $2.30B $2.51B
Other Current Liabilities $99.22B $94.34B $27.29B $26.67B $58.43B $29.62B $30.34B $30.40B $26.28B $28.56B $26.77B $25.06B $22.98B $49.11B $47.31B $21.36B $20.39B $17.97B $16.80B $14.65B
Total Current Liabilities $103.77B $101.56B $104.67B $104.43B $99.05B $114.18B $112.98B $116.48B $89.24B $100.94B $88.70B $88.17B $78.29B $79.58B $76.56B $80.64B $72.42B $66.60B $69.88B $78.61B
Long Term Debt $- $74.10B $63.73B $63.85B $62.12B $58.08B $59.27B $60.66B $58.35B $45.44B $45.80B $40.80B $45.79B $43.34B $44.35B $37.42B $43.09B $39.90B $39.90B $35.78B
Deferred Revenue Non-Current $- $- $-18.43B $3.21B $3.35B $-2.21B $-2.50B $14.49B $2.77B $1.66B $2.21B $2.67B $3.27B $-3.65B $-3.64B $-3.60B $3.37B $-3.34B $-3.29B $-3.03B
Deferred Tax Liabilities Non-Current $- $- $3.63B $4.17B $7.72B $2.21B $2.50B $2.83B $2.77B $1.66B $2.58B $2.95B $3.27B $3.65B $3.64B $3.60B $3.37B $3.34B $3.29B $3.03B
Other Non-Current Liabilities $- $19.19B $14.79B $14.84B $11.94B $13.62B $13.26B $13.08B $8.70B $12.11B $11.97B $11.67B $9.08B $11.84B $12.43B $12.93B $8.39B $11.19B $11.06B $10.05B
Total Non-Current Liabilities $- $93.29B $63.73B $82.86B $80.44B $73.90B $75.03B $76.58B $70.12B $59.21B $60.35B $55.42B $57.44B $58.84B $60.41B $53.95B $54.33B $54.42B $54.24B $48.86B
Other Liabilities $- $- $18.43B $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Total Liabilities $- $194.85B $186.82B $187.29B $179.50B $188.08B $188.01B $193.06B $159.36B $160.14B $149.04B $143.59B $135.73B $138.41B $136.97B $134.59B $126.75B $121.02B $124.13B $127.46B
Preferred Stock $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $-
Common Stock $- $9.00M $9.00M $9.00M $9.00M $9.00M $9.00M $9.00M $9.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M $10.00M
Retained Earnings $- $96.52B $92.40B $90.12B $95.77B $93.17B $89.99B $88.85B $86.16B $83.72B $80.54B $78.78B $77.13B $75.12B $73.09B $71.22B $69.30B $69.72B $67.78B $62.33B
Accumulated Other Comprehensive Income Loss $- $-2.45B $-3.42B $-3.44B $-7.03B $-8.69B $-7.65B $-7.55B $-8.39B $-9.09B $-7.73B $-6.03B $-5.38B $-4.86B $-4.09B $-4.83B $-3.81B $-4.49B $-4.55B $-5.36B
Other Total Stockholders Equity $- $5.81B $373.00M $- $- $- $- $- $- $- $- $- $- $- $- $- $- $- $388.00M $-
Total Stockholders Equity $- $99.88B $84.80B $86.69B $88.76B $84.49B $82.35B $81.31B $77.77B $74.65B $72.82B $72.77B $71.76B $70.28B $69.01B $66.40B $65.49B $65.23B $63.62B $56.98B
Total Equity $4.32B $104.45B $94.68B $96.92B $98.92B $93.98B $92.16B $90.62B $86.35B $82.92B $81.13B $77.65B $76.48B $74.63B $73.32B $70.58B $70.54B $69.95B $68.36B $61.60B
Total Liabilities and Stockholders Equity $298.28B $299.31B $286.06B $284.21B $273.72B $282.06B $280.16B $283.68B $245.71B $243.06B $230.17B $221.24B $212.21B $213.04B $210.29B $205.17B $197.29B $190.97B $192.48B $189.07B
Minority Interest $4.32B $4.57B $9.88B $10.23B $10.16B $9.49B $9.80B $9.31B $8.57B $8.28B $8.31B $4.88B $4.72B $4.35B $4.31B $4.18B $5.05B $4.72B $4.73B $4.63B
Total Liabilities and Total Equity $298.28B $299.31B $286.06B $284.21B $273.72B $282.06B $280.16B $283.68B $245.71B $243.06B $230.17B $221.24B $212.21B $213.04B $210.29B $205.17B $197.29B $190.97B $192.48B $189.07B
Total Investments $52.35B $53.42B $51.15B $9.80B $4.20B $45.47B $45.99B $93.38B $71.64B $45.24B $45.78B $45.27B $45.65B $47.56B $46.79B $45.37B $44.10B $42.44B $40.04B $39.45B
Total Debt $4.54B $78.01B $75.10B $73.64B $67.44B $63.37B $65.59B $70.59B $57.62B $48.67B $51.39B $47.49B $46.00B $46.97B $48.22B $46.26B $43.47B $43.79B $46.06B $51.61B
Net Debt $-24.57B $45.61B $48.81B $45.22B $42.01B $24.45B $19.31B $24.09B $34.26B $9.82B $26.78B $22.01B $24.63B $25.88B $28.38B $26.30B $26.55B $26.24B $23.73B $30.04B

Annual Cash Flow

Breakdown December 31, 2024 December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Net Income $15.24B $22.38B $20.64B $17.73B $15.77B
Depreciation and Amortization $4.10B $3.97B $3.40B $3.10B $2.89B
Deferred Income Tax $- $-245.00M $-1.00B $-814.00M $-60.00M
Stock Based Compensation $1.02B $1.06B $925.00M $800.00M $679.00M
Change in Working Capital $- $1.64B $2.25B $1.52B $2.90B
Accounts Receivables $- $-3.11B $-2.52B $-1.00B $-688.00M
Inventory $- $1.04B $- $-1.03B $-2.19B
Accounts Payables $- $3.52B $1.96B $3.86B $5.50B
Other Working Capital $- $203.00M $2.81B $-310.00M $278.00M
Other Non Cash Items $3.85B $258.00M $7.24B $6.64B $6.77B
Net Cash Provided by Operating Activities $24.20B $29.07B $26.21B $22.34B $22.17B
Investments in Property Plant and Equipment $-3.50B $-3.39B $-2.80B $-2.45B $-2.05B
Acquisitions Net $-13.41B $-10.14B $-21.46B $-4.82B $-7.14B
Purchases of Investments $525.00M $-18.31B $-6.84B $-1.84B $-2.84B
Sales Maturities of Investments $- $16.54B $11.99B $15.30B $13.74B
Other Investing Activities $-4.14B $-275.00M $-9.37B $-16.55B $-14.25B
Net Cash Used for Investing Activities $-20.53B $-15.57B $-28.48B $-10.37B $-12.53B
Debt Repayment $- $4.28B $12.54B $2.48B $1.71B
Common Stock Issued $- $1.35B $1.25B $1.35B $1.44B
Common Stock Repurchased $-9.00B $-8.00B $-7.00B $-5.00B $-4.25B
Dividends Paid $-7.53B $-6.76B $-5.99B $-5.28B $-4.58B
Other Financing Activities $4.02B $-2.40B $3.43B $-1.01B $2.09B
Net Cash Used Provided by Financing Activities $-3.51B $-11.53B $4.23B $-7.46B $-3.59B
Effect of Forex Changes on Cash $-61.00M $97.00M $34.00M $-62.00M $-116.00M
Net Change in Cash $-115.00M $2.06B $1.99B $4.45B $5.94B
Cash at End of Period $25.31B $25.43B $23.36B $21.38B $16.92B
Cash at Beginning of Period $25.43B $23.36B $21.38B $16.92B $10.98B
Operating Cash Flow $24.20B $29.07B $26.21B $22.34B $22.17B
Capital Expenditure $-3.50B $-3.39B $-2.80B $-2.45B $-2.05B
Free Cash Flow $20.70B $25.68B $23.40B $19.89B $20.12B

Cash Flow Charts

Breakdown September 30, 2024 June 30, 2024 March 31, 2024 December 31, 2023 September 30, 2023 June 30, 2023 March 31, 2023 December 31, 2022 September 30, 2022 June 30, 2022 March 31, 2022 December 31, 2021 September 30, 2021 June 30, 2021 March 31, 2021 December 31, 2020 September 30, 2020 June 30, 2020 March 31, 2020 December 31, 2019
Net Income $6.05B $4.22B $-1.41B $5.46B $6.04B $5.66B $5.77B $4.91B $5.38B $5.20B $5.15B $4.19B $4.19B $4.37B $4.98B $2.35B $3.26B $6.70B $3.46B $3.67B
Depreciation and Amortization $1.04B $1.02B $997.00M $974.00M $1.01B $1.02B $970.00M $982.00M $828.00M $802.00M $788.00M $771.00M $796.00M $778.00M $758.00M $732.00M $719.00M $717.00M $723.00M $718.00M
Deferred Income Tax $124.00M $-331.00M $-27.00M $249.00M $-71.00M $-241.00M $-263.00M $-414.00M $-790.00M $-176.00M $178.00M $-992.00M $65.00M $-173.00M $286.00M $-227.00M $-71.00M $-9.00M $247.00M $128.00M
Stock Based Compensation $237.00M $222.00M $372.00M $208.00M $247.00M $242.00M $362.00M $250.00M $171.00M $205.00M $299.00M $209.00M $165.00M $170.00M $256.00M $152.00M $139.00M $157.00M $231.00M $172.00M
Change in Working Capital $6.82B $-91.00M $-6.24B $-11.85B $-410.00M $4.42B $9.48B $-10.26B $12.96B $643.00M $-1.09B $-961.00M $2.36B $393.00M $-273.00M $3.09B $-916.00M $2.44B $-1.72B $1.52B
Accounts Receivables $2.47B $3.69B $-6.16B $-540.00M $-2.77B $4.50B $-4.31B $40.00M $1.64B $317.00M $-4.52B $-153.00M $371.00M $1.68B $-2.90B $-494.00M $245.00M $2.21B $-2.65B $-795.00M
Inventory $- $- $- $-441.00M $1.07B $-185.00M $- $- $- $- $- $404.00M $88.00M $-568.00M $-955.00M $502.00M $1.09B $465.00M $-4.25B $618.00M
Accounts Payables $- $267.00M $-231.00M $1.15B $823.00M $-249.00M $4.26B $-3.64B $772.00M $218.00M $4.44B $-1.23B $1.71B $-454.00M $3.84B $2.67B $-2.41B $-19.00M $5.26B $1.63B
Other Working Capital $4.34B $-563.00M $9.00M $-12.02B $466.00M $353.00M $9.53B $-6.66B $10.54B $-518.00M $-1.01B $21.00M $192.00M $-262.00M $-261.00M $410.00M $164.00M $-217.00M $-79.00M $70.00M
Other Non Cash Items $-328.00M $3.64B $9.79B $-226.00M $91.00M $-69.00M $2.20B $1.95B $1.16B $198.00M $2.17B $879.00M $1.93B $1.66B $-55.00M $-100.00M $-76.00M $79.00M $45.00M $75.00M
Net Cash Provided by Operating Activities $13.95B $6.75B $1.14B $-5.19B $6.90B $11.03B $16.33B $-4.53B $18.55B $6.87B $5.32B $3.22B $7.58B $5.54B $6.00B $6.10B $3.13B $10.00B $2.94B $6.21B
Investments in Property Plant and Equipment $-991.00M $-853.00M $-743.00M $-959.00M $-838.00M $-829.00M $-760.00M $-866.00M $-724.00M $-657.00M $-555.00M $-695.00M $-629.00M $-562.00M $-568.00M $-574.00M $-557.00M $-451.00M $-469.00M $-650.00M
Acquisitions Net $-8.64B $-25.00M $-3.01B $-1.79B $-228.00M $-335.00M $-7.83B $-14.30B $-4.00M $-5.92B $-1.23B $-94.00M $-85.00M $-3.45B $-1.19B $-2.81B $-374.00M $-3.02B $-929.00M $-143.00M
Purchases of Investments $-9.82B $-5.33B $-4.80B $-5.32B $6.38B $3.32B $-2.32B $-2.77B $-701.00M $-3.92B $-1.63B $1.86B $5.14B $-4.24B $-4.61B $-1.45B $5.03B $-2.55B $-3.87B $-476.00M
Sales Maturities of Investments $11.89B $4.62B $5.29B $6.39B $-7.65B $-2.58B $2.58B $1.87B $4.58B $2.19B $3.35B $6.17B $3.07B $3.16B $2.90B $3.56B $3.20B $543.00M $30.00M $4.27B
Other Investing Activities $1.91B $-5.83B $-3.08B $-239.00M $-297.00M $-309.00M $-2.69B $699.00M $-4.00B $-277.00M $-3.60B $-6.53B $-9.38B $-416.00M $-232.00M $-3.90B $-10.16B $2.52B $3.70B $-4.39B
Net Cash Used for Investing Activities $-5.65B $-7.42B $-6.34B $-1.92B $-2.64B $-728.00M $-11.02B $-15.37B $-847.00M $-8.59B $-3.67B $716.00M $-1.88B $-5.50B $-3.71B $-5.18B $-2.87B $-2.95B $-1.53B $-1.39B
Debt Repayment $2.33B $1.43B $11.36B $-1.57B $-1.85B $-4.68B $12.38B $8.73B $-2.36B $4.11B $2.05B $-1.25B $-1.12B $-750.00M $2.91B $-355.00M $-2.27B $-5.58B $10.80B $-500.00M
Common Stock Issued $867.00M $258.00M $486.00M $314.00M $411.00M $284.00M $344.00M $169.00M $328.00M $205.00M $551.00M $278.00M $313.00M $328.00M $436.00M $234.00M $336.00M $313.00M $557.00M $297.00M
Common Stock Repurchased $-956.00M $- $-3.07B $-1.50B $-1.50B $-3.00B $-2.00B $-1.00B $-1.00B $-2.50B $-2.50B $-1.05B $-1.05B $-1.25B $-1.65B $-1.71B $-850.00M $- $-1.69B $-399.00M
Dividends Paid $-1.94B $-1.94B $-1.73B $-1.74B $-1.74B $-1.75B $-1.54B $-1.54B $-1.54B $-1.54B $-1.36B $-1.36B $-1.37B $-1.37B $-1.18B $-1.18B $-1.19B $-1.19B $-1.02B $-1.02B
Other Financing Activities $-2.51B $-945.00M $1.18B $-1.93B $-2.43B $-1.32B $4.01B $-1.97B $1.15B $672.00M $3.57B $-238.00M $-1.17B $2.82B $275.00M $1.42B $-1.04B $178.00M $664.00M $-4.59B
Net Cash Used Provided by Financing Activities $-2.21B $-1.20B $8.23B $-6.43B $-7.10B $-10.46B $13.19B $4.39B $-3.42B $946.00M $2.30B $-3.63B $-4.40B $-218.00M $787.00M $-1.60B $-5.02B $-6.28B $9.30B $-6.21B
Effect of Forex Changes on Cash $14.00M $4.00M $-48.00M $48.00M $-57.00M $55.00M $51.00M $30.00M $-53.00M $-100.00M $157.00M $-17.00M $-51.00M $57.00M $-51.00M $44.00M $-17.00M $-14.00M $-129.00M $17.00M
Net Change in Cash $6.11B $-2.13B $2.99B $-13.49B $-2.90B $-100.00M $18.55B $-15.48B $14.23B $-870.00M $4.11B $290.00M $1.25B $-123.00M $3.03B $-629.00M $-4.78B $758.00M $10.58B $-1.38B
Cash at End of Period $32.40B $26.29B $28.41B $25.43B $38.91B $41.81B $41.91B $23.36B $38.84B $24.61B $25.48B $21.38B $21.09B $19.83B $19.95B $16.92B $17.55B $22.33B $21.57B $10.98B
Cash at Beginning of Period $26.29B $28.41B $25.43B $38.91B $41.81B $41.91B $23.36B $38.84B $24.61B $25.48B $21.38B $21.09B $19.83B $19.95B $16.92B $17.55B $22.33B $21.57B $10.98B $12.36B
Operating Cash Flow $13.95B $6.75B $1.14B $-5.19B $6.90B $11.03B $16.33B $-4.53B $18.55B $6.87B $5.32B $3.22B $7.58B $5.54B $6.00B $6.10B $3.13B $10.00B $2.94B $6.21B
Capital Expenditure $-991.00M $-853.00M $-743.00M $-959.00M $-838.00M $-829.00M $-760.00M $-866.00M $-724.00M $-657.00M $-555.00M $-695.00M $-629.00M $-562.00M $-568.00M $-574.00M $-557.00M $-451.00M $-469.00M $-650.00M
Free Cash Flow $12.95B $5.89B $401.00M $-6.15B $6.06B $10.20B $15.57B $-5.40B $17.82B $6.21B $4.76B $2.52B $6.95B $4.98B $5.44B $5.53B $2.57B $9.55B $2.47B $5.55B


UnitedHealth Group Stock Forecast

Analyst ratings, price targets, and earnings estimates for UNH.

UNH Analyst Ratings

Strong Buy

Buy
27
Hold
3
Sell
2

Based on 32 analysts in the past 3 months

UNH Stock 12 Month Forecast

$635.00

▲ (19.94% Upside)
Highest Price Target
$ (0.0%)
Average Price Target
$635.00 (19.9%)
Lowest Price Target
$ (0.0%)

Based on 1 analysts in the last 3 months

Recent Price Targets
Recommendation Trends
Analyst Estimates
Revenue Estimates
High $453.62B
Average $450.84B
Low $441.54B
18 analysts
Net Income Estimates
High $28.04B
Average $27.28B
Low $26.52B
18 analysts
EPS Estimates
High $30.18
Average $29.72
Low $28.54
20 analysts
Revenue Estimates
High $497.96B
Average $486.57B
Low $469.84B
19 analysts
Net Income Estimates
High $31.90B
Average $30.95B
Low $30.00B
19 analysts
EPS Estimates
High $34.34
Average $33.50
Low $32.29
19 analysts
Revenue Estimates
High $523.71B
Average $522.61B
Low $521.51B
12 analysts
Net Income Estimates
High $36.87B
Average $35.03B
Low $33.18B
12 analysts
EPS Estimates
High $39.69
Average $38.08
Low $35.72
8 analysts
Revenue Estimates
High $599.90B
Average $589.76B
Low $571.09B
6 analysts
Net Income Estimates
High $41.65B
Average $40.74B
Low $39.06B
6 analysts
EPS Estimates
High $44.83
Average $43.85
Low $42.05
7 analysts
Revenue Estimates
High $687.44B
Average $675.82B
Low $654.43B
11 analysts
Net Income Estimates
High $48.09B
Average $47.04B
Low $45.10B
11 analysts
EPS Estimates
High $51.76
Average $50.63
Low $48.55
6 analysts
Latest Price Target Updates
Date Analyst Firm Price Target Price When Posted Upside
Dec 09, 2024 David Windley Jefferies $635.00 $549.53 15.6%
Oct 16, 2024 Ben Hendrix RBC Capital $595.00 $556.29 7.0%
Oct 16, 2024 David MacDonald Truist Financial $625.00 $556.29 12.4%
Oct 16, 2024 Joanna Gajuk Bank of America Securities $650.00 $556.29 16.8%
Oct 16, 2024 David Windley Jefferies $643.00 $556.29 15.6%
Oct 16, 2024 George Hill Deutsche Bank $595.00 $556.29 7.0%
Oct 16, 2024 Matthew Gillmor KeyBanc $650.00 $569.66 14.1%
Oct 10, 2024 Matthew Gillmor KeyBanc $675.00 $597.70 12.9%
Jul 17, 2024 David Toung Argus Research $600.00 $565.78 6.0%
Jul 17, 2024 David MacDonald Truist Financial $640.00 $548.87 16.6%

UnitedHealth Group Dividends

Explore UnitedHealth Group's dividend history, including dividend yield, payout ratio, and historical payments.

Dividend Yield

1.60%

Dividend Payout Ratio

52.29%

Dividend Paid & Capex Coverage Ratio

2.19x



UnitedHealth Group Dividend History

Dividend Adjusted Dividend Date Record Date Payment Date Declaration Date
$2.1 $2.1 December 09, 2024 December 09, 2024 December 17, 2024 November 06, 2024
$2.1 $2.1 September 16, 2024 September 16, 2024 December 17, 2024 November 06, 2024
$2.1 $2.1 June 17, 2024 June 17, 2024 June 25, 2024 June 05, 2024
$1.88 $1.88 March 08, 2024 March 11, 2024 March 19, 2024 February 23, 2024
$1.88 $1.88 December 01, 2023 December 04, 2023 December 12, 2023 November 08, 2023
$1.88 $1.88 September 08, 2023 September 11, 2023 September 19, 2023 August 23, 2023
$1.88 $1.88 June 15, 2023 June 19, 2023 June 27, 2023 June 07, 2023
$1.65 $1.65 March 10, 2023 March 13, 2023 March 21, 2023 February 27, 2023
$1.65 $1.65 December 02, 2022 December 05, 2022 December 13, 2022 November 04, 2022
$1.65 $1.65 September 09, 2022 September 12, 2022 September 20, 2022 August 17, 2022
$1.65 $1.65 June 16, 2022 June 20, 2022 June 28, 2022 June 08, 2022
$1.45 $1.45 March 11, 2022 March 14, 2022 March 22, 2022 February 16, 2022
$1.45 $1.45 December 03, 2021 December 06, 2021 December 14, 2021 November 05, 2021
$1.45 $1.45 September 10, 2021 September 13, 2021 September 21, 2021 August 11, 2021
$1.45 $1.45 June 18, 2021 June 21, 2021 June 29, 2021 June 09, 2021
$1.25 $1.25 March 12, 2021 March 15, 2021 March 23, 2021 February 24, 2021
$1.25 $1.25 December 04, 2020 December 07, 2020 December 15, 2020 November 04, 2020
$1.25 $1.25 September 11, 2020 September 14, 2020 September 22, 2020 August 05, 2020
$1.25 $1.25 June 19, 2020 June 22, 2020 June 30, 2020 June 02, 2020
$1.08 $1.08 March 13, 2020 March 16, 2020 March 24, 2020 February 17, 2020

Peers: Medical - Healthcare Plans

This section provides companies within the same sector, on the same exchange, and of similar market capitalization, allowing comparisons of key financial indicators among peers.

Company Market Cap Price EPS P/E Ratio P/B Ratio
CI Logo
Cigna Corporation
CI
$79.43B $285.57 $17.57 $17.04 $1.90
HUM Logo
Humana Inc.
HUM
$33.59B $278.93 $20.09 $22.78 $3.49
ELV Logo
Elevance Health Inc.
ELV
$90.37B $389.67 $25.62 $14.40 $0.00
CNC Logo
Centene Corporation
CNC
$29.51B $58.45 $6.33 $9.56 $0.00
MOH Logo
Molina Healthcare, Inc.
MOH
$16.24B $284.00 $20.43 $14.24 $0.00
CVS Logo
CVS Health Corporation
CVS
$68.60B $54.51 $6.49 $12.16 $1.33
ALHC Logo
Alignment Healthcare, Inc.
ALHC
$2.86B $14.94 $-0.79 $-10.83 $10.22
Ownership